Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases

BACKGROUND: Yttrium-90 (Y-90) can be an effective liver-directed therapy for patients with metastatic neuroendocrine tumors (NETs), but population-based data are limited. We characterized the use of Y-90 in NET patients and identified factors associated with response. METHODS: We identified 49 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsang, Erica S., Loree, Jonathan M., Davies, Janine M., Gill, Sharlene, Liu, David, Ho, Stephen, Renouf, Daniel J., Lim, Howard J., Kennecke, Hagen F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704205/
https://www.ncbi.nlm.nih.gov/pubmed/33299824
http://dx.doi.org/10.1155/2020/5104082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704205/
https://www.ncbi.nlm.nih.gov/pubmed/33299824
http://dx.doi.org/10.1155/2020/5104082

Ejemplares similares